1-(3-Iodo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrol-1-yl)-2,2-dimethylpropan-1-one

Catalog No. :
ACLVLS327
CAS No. :
2624041-04-7
Molecular Formula :
C15H23BINO3
Molecular Weight :
403.07

IUPAC Name:1-(3-iodo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrol-1-yl)-2,2-dimethylpropan-1-one

1-(3-Iodo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrol-1-yl)-2,2-dimethylpropan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Iodo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrol-1-yl)-2,2-dimethylpropan-1-one
IUPAC Name1-(3-iodo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrol-1-yl)-2,2-dimethylpropan-1-one
Molecular FormulaC15H23BINO3
Molecular Weight403.07
SMILESO=C(C(C)(C)C)N1C=CC(I)=C1B2OC(C)(C(C)(C)O2)C
InChI KeyLXNAMAQDJGDZGA-UHFFFAOYSA-N
Synonym1-Propanone, 1-[3-iodo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrol-1-yl]-2,2-dimethyl-
CAS No.2624041-04-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACLVLS327 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVLS327 route product structure diagram
    ACLVLS3272624041-04-7
Inquiry

2. ACLVLS327 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVLS327 route product structure diagram
    ACLVLS3272624041-04-7
Inquiry

Comments (0)